当前位置: X-MOL 学术J. Diabetes › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.
Journal of Diabetes ( IF 3.0 ) Pub Date : 2019-07-10 , DOI: 10.1111/1753-0407.12959
Aini Haddouche 1 , Christine Bellanne-Chantelot 2 , Anne Rod 1 , Luc Fournier 3 , Laurence Chiche 4 , Jean-Francois Gautier 5 , Jose Timsit 6 , Sandrine Laboureau 7 , Lucy Chaillous 8 , Rene Valero 9 , Etienne Larger 6 , Nathalie Jeandidier 10 , Jean-Marie Wilhelm 11 , Marc Popelier 12 , Pierre-Jean Guillausseau 13 , Charles Thivolet 14 , Pierre Lecomte 15 , Pierre-Yves Benhamou 16 , Yves Reznik 1
Affiliation  

Liver adenomatosis (LA) is a rare disease resulting from biallelic inactivation of the hepatocyte nuclear factor‐1 alpha (HNF1A) gene, which induces the proliferation of adenoma cells in liver parenchyma. Liver adenomatosis has only been documented in case reports from patients carrying a HNF1A germline mutation. We have evaluated the frequency of LA among a large cohort of patients with HNF1A‐maturity onset diabetes of the young (MODY), previously termed “MODY3,” and herein describe its clinical, radiological, and pathological characteristics.

中文翻译:

年轻肝细胞核因子 1 α 成熟型糖尿病 (HNF1A-MODY) 患者的肝腺瘤病:法国系列的临床、放射学和病理学特征。

肝腺瘤病 (LA) 是一种罕见疾病,由肝细胞核因子 1 α ( HNF1A ) 基因双等位基因失活引起,可诱导肝实质中腺瘤细胞增殖。仅在携带HNF1A种系突变的患者的病例报告中记录了肝腺瘤病。我们评估了一大群HNF1A青少年发病型糖尿病 (MODY)(以前称为“MODY3”)患者中 LA 的频率,并在本文中描述了其临床、放射学和病理学特征。
更新日期:2019-07-10
down
wechat
bug